EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Impact of elexacaftor/tezacaftor/ivacaftor therapy on P2X7R airway epithelial cell expression and inflammasome signalling in cystic fibrosis

Debananda Gogoi, Rory Baird, Azeez Yusuf, Karin Pietsch, Caoimbhe Bolger, Sabrina Alghamdi, Parisa Acquilini, Lorraine DCosta, Olive McCabe, Cedric Gunaratnam, Michelle Casey, Emer P Reeves iD

Innate Immunity · 2026-11 · 32

DOI: 10.1177/17534259261503719 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Innate Immunity, online erschienen am 11.11.2026. Verfasst von Debananda Gogoi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonary Clinical Science, Department of Anaesthesia and Critical Care Medicine, RCSI University of Medicine and Health Sciences, Dublin, Ireland. Hauptthemen laut MEDLINE: Cystic Fibrosis, Receptors, Purinergic P2X7, Inflammasomes, Aminophenols. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Cystic Fibrosis Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Purinergic receptor activation via extracellular adenosine-5′-triphosphate (eATP) is involved in the pathogenesis of cystic fibrosis (CF) through P2X7-receptor (P2X7R) mediated NLRP3 (NOD-, LRR-, and pyrin-domain-containing protein 3) inflammasome activation and interleukin-1β (IL-1β) production.

Objectives

The aim of this study was to explore P2X7R expression in nasal (NECs) and airway epithelial cells (AECs) of people with CF (pwCF), and to record the in vivo and in vitro impact of CFTR modulator elexacaftor/tezacaftor/ivacaftor (ETI) therapy.

Methods

CFTR and P2X7R expression levels were measured in vivo in CF NECs (n=5) before and after 12 months ETI therapy, or in vitro , in normal (NuLi-1) and CF (CuFi-1, Phe508del/Phe508del genotype) AECs. NLRP3 expression, caspase-1 activity and IL-1β secretion were measured in AECs, and following stimulation with ATP and lipopolysaccharides (LPS).

Results

P2X7R is overexpressed in CF NECs in vivo (p=0.0079), in CF AECs (CuFi-1, Phe508del/Phe508del genotype) in vitro (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisReceptors, Purinergic P2X7InflammasomesAminophenolsIndolesQuinolonesEpithelial CellsBenzodioxolesPyrrolesPyrazolesPyridinesHumansNLR Family, Pyrin Domain-Containing 3 ProteinSignal TransductionCystic Fibrosis Transmembrane Conductance RegulatorInterleukin-1betaMaleCells, CulturedFemaleOxadiazolesPyrrolidines

Stichwörter der Autor:innen

Airway epithelial cellsCFTR modulator therapyCystic fibrosisNLRP3-inflammasomeP2X7Rinterleukin-1β

Substanzen

Receptors, Purinergic P2X7InflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinAminophenolsIndolestezacaftorQuinolonesCystic Fibrosis Transmembrane Conductance RegulatorInterleukin-1betaelexacaftor

Autor:innen und Institutionen

  • Pulmonary Clinical Science, Department of Anaesthesia and Critical Care Medicine, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
  • Office of Research and Innovation, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
  • Cystic Fibrosis Unit, Department of Respiratory Medicine, Beaumont Hospital, Dublin, Ireland.

ORCID-Profile: Emer P Reeves

Förderung

  • Cystic Fibrosis Foundation

Zitieren

APA

Gogoi, D., Baird, R., Yusuf, A., Pietsch, K., Bolger, C., Alghamdi, S., Acquilini, P., DCosta, L., McCabe, O., Gunaratnam, C., Casey, M., & Reeves, E. P. (2026). Impact of elexacaftor/tezacaftor/ivacaftor therapy on P2X7R airway epithelial cell expression and inflammasome signalling in cystic fibrosis. Innate Immunity, 32. https://doi.org/10.1177/17534259261503719

Vancouver

Gogoi D, Baird R, Yusuf A, Pietsch K, Bolger C, Alghamdi S, et al. Impact of elexacaftor/tezacaftor/ivacaftor therapy on P2X7R airway epithelial cell expression and inflammasome signalling in cystic fibrosis. Innate Immunity. 2026;32. doi:10.1177/17534259261503719

BibTeX
@article{Gogoi2026,
  author = {Gogoi, Debananda and Baird, Rory and Yusuf, Azeez and Pietsch, Karin and Bolger, Caoimbhe and Alghamdi, Sabrina and Acquilini, Parisa and DCosta, Lorraine and McCabe, Olive and Gunaratnam, Cedric and Casey, Michelle and Reeves, Emer P},
  title = {Impact of elexacaftor/tezacaftor/ivacaftor therapy on P2X7R airway epithelial cell expression and inflammasome signalling in cystic fibrosis},
  journal = {Innate Immunity},
  year = {2026},
  volume = {32},
  doi = {10.1177/17534259261503719}
}
Kostenlos starten →